Dasatinib-d8(CAS: 1132093-70-9)

Dasatinib-d8 (CAS: 1132093-70-9) is regulated under GHS classification as a hazardous chemical. In the European Union, it is covered by REACH regulations, which require manufacturers to register substances above one tonne per year. FDA and EPA have specific guidelines for the import, production, and use of this compound in pharmaceuticals and research.

Alternative reagents such as dasatinib-d4 and dasatinib-d6 are used as isotopically labeled analogs. Isomers like cis-dasatinib and trans-dasatinib may also be considered. Synthesizers often explore these options to achieve similar labeling or structural modifications.

The market for Dasatinib-d8 (CAS: 1132093-70-9) is growing due to its use in pharmaceutical research, particularly in studying the metabolism and pharmacokinetics of dasatinib. Recent trends show an increase in demand for isotopically labeled compounds to enhance drug development and safety assessments.

Waste containing Dasatinib-d8 (CAS: 1132093-70-9) should be collected in a sealed, leak-proof container and disposed of through a licensed hazardous waste management facility. Incineration is a common method, and environmental protection precautions must be followed to prevent contamination of soil and water.